Jen WY, Marvin-Peek J, Kantarjian HM, Alvarado Y, et al. Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia. Cancer 2024 Nov 25. doi: 10.1002/cncr.35662.
PMID: 39584789